Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

Presentation TCT Abstracts Posters 2018

Non-Contrast Cardiovascular MRI for TAVR: Paradigm shift?

Presenter: Pravin Patil

September 25, 2018

Presentation TCT 2018

Cardiac MRI as Physiologic Gatekeeper: The MR-INFORM Trial

Presenter: Pamela S. Douglas, Javier Escaned, Colin Berry

September 24, 2018

Presentation SCAD 2018

Diagnosis of SCAD on CTA & MRI

Presenter: John R. Mayo

September 08, 2018

News Daily News

Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk

Michael O'Riordan

June 20, 2018

News Conference News EuroPCR 2018

Modest Benefit of PCI Over Medical Therapy in Patients With ‘Grey Zone’ FFR Lesions

Michael O'Riordan

May 23, 2018

Presentation ECHO 2018

Evaluation of the Athlete

Presenter: Karen Stout

April 20, 2018

Presentation ECHO 2018

CMR for Valvular Heart Disease

Presenter: Omar Khalique

April 19, 2018

News Daily News

Silent MI Often Precedes Acute MI, Portends Worse Patient Outcomes

Shelley Wood

April 18, 2018

Presentation ECHO 2018

Chamber Quantitation Guidelines Update:Right Heart Measurements

Presenter: Linda D. Gillam

April 18, 2018

Presentation ECHO 2018

Quantitation of the Left Heart

Presenter: Gerard P. Aurigemma

April 18, 2018

News Industry News

Medtronic Expands Visualase(TM) MRI-Guided Laser Ablation System to European Markets with CE Mark Approval

April 16, 2018

News Daily News

LV Diastolic Dysfunction Linked With Higher Mortality Post-TAVR

Yael L. Maxwell

March 01, 2018

News Daily News

Existing Neurocognitive Deficits Cloud Interpretation of Post-TAVR Changes: SENTINEL Analysis

Caitlin E. Cox

February 05, 2018

News Daily News

Surprising Rate of Cardiac Amyloidosis in TAVR Patients Poses Tough Questions for Diagnosis, Decision-Making

Michael O'Riordan

February 01, 2018

Presentation Controversies and Advances 2017

HFPEF – Echo with Strain vs. MRI T1 Mapping

Presenter: Eric Schelbert

November 17, 2017

Presentation Controversies and Advances 2017

Update in Nuclear Imaging of Amyloidosis and Sarcoidosis

Presenter: Balaji Tamarappoo

November 17, 2017

Advertisement

Non-Contrast Cardiovascular MRI for TAVR: Paradigm shift?

Cardiac MRI as Physiologic Gatekeeper: The MR-INFORM Trial

Diagnosis of SCAD on CTA & MRI

Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk

Modest Benefit of PCI Over Medical Therapy in Patients With ‘Grey Zone’ FFR Lesions

Evaluation of the Athlete

CMR for Valvular Heart Disease

Silent MI Often Precedes Acute MI, Portends Worse Patient Outcomes

Chamber Quantitation Guidelines Update:Right Heart Measurements

Quantitation of the Left Heart

Medtronic Expands Visualase(TM) MRI-Guided Laser Ablation System to European Markets with CE Mark Approval

LV Diastolic Dysfunction Linked With Higher Mortality Post-TAVR

Existing Neurocognitive Deficits Cloud Interpretation of Post-TAVR Changes: SENTINEL Analysis

Surprising Rate of Cardiac Amyloidosis in TAVR Patients Poses Tough Questions for Diagnosis, Decision-Making

HFPEF – Echo with Strain vs. MRI T1 Mapping

Update in Nuclear Imaging of Amyloidosis and Sarcoidosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content